Martin Bornhäuser
Dresden haematologist and transplant physician who co-directs the NCT/UCC Dresden cancer centre and leads AML transplant trials.
Overview
Martin Bornhäuser is one of three Managing Directors of the National Center for Tumor Diseases (NCT/UCC) Dresden and Director of Medizinische Klinik und Poliklinik I at University Hospital Carl Gustav Carus. His research focuses on allogeneic stem cell transplantation and acute myeloid leukaemia, including the ASAP trial of immediate transplantation in relapsed or refractory AML. His role is listed on the NCT/UCC Direktorium page.
| Title | Journal | Year |
|---|---|---|
| Multiple myeloma | Lancet | 2015 |
| Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP) | Lancet Haematology | 2024 |
Pages like this
not linked directly; found by shared links- PersonBrian Huntly
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
- PersonKonstanze Döhner
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
- PersonHubert Serve
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
- PersonThomas Kindler
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
- PersonHanno Glimm
Shares NCT/UCC Dresden – University Hospital Carl Gustav Carus and the tags leadership, clinician-scientist.
- PersonNicolaas P.M. Schaap
Shares Multiple myeloma, Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
- PersonJürgen Kuball
Shares Multiple myeloma, Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
- PersonTim Somervaille
Shares Acute myeloid leukaemia and the tags clinician-scientist, haematology, leukaemia.